Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

.19 due to the 6.9% increase in net income and a lower ADS count caused by the company's purchase of 2,846,375 ADSs from General Atlantic in February 2012 and of 2,138,993 ADSs, at an average price of $14.03 per ADS, in the open market during the second and third quarters of 2012.

Full-year 2012 GAAP comprehensive income decreased 11.9% year over year to $87.9 million due to the decrease in currency translation adjustments, partially offset by the 6.9% increase in GAAP net income.

Fourth-Quarter Non-GAAP ResultsNon-GAAP financial results exclude the impact of share-based compensation expenses, the amortization of acquired intangible assets and the associated deferred tax impact, impairment charges for goodwill and intangible assets, and revaluation of contingent consideration. 

Fourth-quarter 2012 non-GAAP gross profit increased 13.7% year over year to $50.0 million mainly due to broad-based revenue growth, offset by lower gross margin.  Non-GAAP gross margin decreased year over year to 39.8% from 40.5%.  Non-GAAP gross margin in Laboratory Services decreased mainly due to increased labor costs, investment in new businesses, appreciation of the RMB versus the U.S. dollar, and lower pricing in chemistry services, partially offset by improved productivity.  Non-GAAP gross margin in Manufacturing Services decreased mainly due to lower capacity utilization in our commercial manufacturing business.Fourth-quarter 2012 non-GAAP operating income increased 15.1% year over year to $27.4 million, primarily due to the 13.7% increase in non-GAAP gross profit and slower growth in operating expenses.  Operating margin decreased slightly to 21.8% from 21.9% due to lower gross margin, partially offset by slower growth in operating expenses.

Fourth-quarter 2012 non-GAAP net income grew 2.1% year over year to $27.5 million due to the 15.1% increase in non-GAAP operating income, offset by a 33.6% decrease in other income / (expense
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Global Insulin Patch Market ... Highly advanced technology like ultrasound and iontophoresis ... insulin patches. Depending upon the type of technique, ... of reach of several patients. In long-term, it ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Therapy Reduces TNF-alpha Production Through Inhibition,of PDE-4 ... /PRNewswire/ -- Anacor,Pharmaceuticals, a privately held pharmaceutical ... Phase 1 trial of,AN2728, a first-in-class topical ... The trial showed AN2728 to be,well-tolerated, with ...
... and Pharmacokinetics Similar to IV Doses in,Phase ... 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... Company's lead anti-cancer drug,Genasense(R) (oblimersen sodium) injection, ... injection, as well,as by brief intravenous (IV) ...
Cached Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after ... Florida while under the influence of Flakka, according to ... by CBS4’s Peter D’Oench records Doby distraught in a parking ... one year old. The drug treatment center in Florida who ... The residents polled by CBS Miami express concern about the ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... annual charity softball game. The event takes place on Friday, ... Past years guests include Joe Flacco, John Harbaugh, Ed Reed ... sale if you are interested in attending. , The ... as SOAR Baltimore and The CollegeBound Foundation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... , OMAHA, Neb. and PHOENIX, Ariz., June 30 ... Joseph,s Hospital and Medical Center in Phoenix today announced an ... school presence in Phoenix. , , The Phoenix ... School of Medicine at St. Joseph,s Hospital and Medical Center, ...
... infection to treat and requires six months of multiple ... pandemic, a shorter and simpler drug treatment would be ... settings with poor public health infrastructures. ... which TB patients could benefit from shorter treatment, researchers ...
... Community Improvement , , MINNEAPOLIS, June 30 ... and a leader in financial clearing services for health ... the Ernst & Young Entrepreneur Of The Year(R) 2009 ... region. According to Ernst & Young LLP, the award ...
... Partnership to Fight Chronic Disease (PFCD), a coalition committed to ... comprehensive health reform, hosted a breakfast meeting today where partner ... and care. , , America spends more ... percent - or $1.7 trillion - of that spending is ...
... Ultrasound in Medicine (AIUM) has reached a management ... (ISTU) effective July 1, 2009. The AIUM will ... functions in an effort to maximize the ISTU,s ... "The AIUM recognizes therapeutic ultrasound as a ...
... 30 /PRNewswire/ - Winnipeg-based medical device company Intelligent ... Century Achievement Award during the Computerworld Honors Program ... D.C. IH Systems received the award in recognition ... world,s first solution combining software, robotics and engineering ...
Cached Medicine News:Health News:Creighton University, St. Joseph's Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 2Health News:Measurements fail to identify TB patients who could benefit from shorter treatment course 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 3Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: